Laura Soucek | |
|---|---|
| Born | |
| Alma mater | Sapienza University of Rome University of California, San Francisco |
| Scientific career | |
| Institutions | Vall d'Hebron Institute of Oncology, ICREA, UAB |
Laura Soucek (born 1973) is a Group Leader at VHIO (the Vall d'Hebron Institute of Oncology), Research Professor at ICREA, and CEO of Peptomyc S.L. She works on the Myc oncoprotein, the deregulation of which occurs during almost all cancers. Soucek has designed a dominant negative variant, Omomyc, which allows her to investigate the benefits of inhibiting Myc in cancer.